These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8747757)

  • 1. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.
    Kosten TA; DeCaprio JL; Rosen MI
    Neuropsychopharmacology; 1995 Dec; 13(4):323-33. PubMed ID: 8747757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
    Christensen D; Guilbaud G; Kayser V
    Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
    Bristow LJ; Hogg JE; Hutson PH
    Neuropharmacology; 1997 Feb; 36(2):241-50. PubMed ID: 9144662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats.
    Ayoub SM; Smoum R; Farag M; Atwal H; Collins SA; Rock EM; Limebeer CL; Piscitelli F; Iannotti FA; Lichtman AH; Leri F; Di Marzo V; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2020 Sep; 237(9):2753-2765. PubMed ID: 32556401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
    Harris AC; Rothwell PE; Gewirtz JC
    Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
    Taylor JR; Punch LJ; Elsworth JD
    Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
    Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
    Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute naloxone-precipitated morphine withdrawal elicits nausea-like somatic behaviors in rats in a manner suppressed by N-oleoylglycine.
    Rock EM; Ayoub SM; Limebeer CL; Gene A; Wills KL; DeVuono MV; Smoum R; Di Marzo V; Lichtman AH; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2020 Feb; 237(2):375-384. PubMed ID: 31712968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
    Kawasaki Y; Jin C; Suemaru K; Kawasaki H; Shibata K; Choshi T; Hibino S; Gomita Y; Araki H
    Br J Pharmacol; 2005 Jul; 145(6):751-7. PubMed ID: 15880144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.
    Popik P; Mamczarz J; Fraczek M; Widła M; Hesselink M; Danysz W
    Neuropharmacology; 1998 Aug; 37(8):1033-42. PubMed ID: 9833632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate physical dependence and N-methyl-D-aspartate receptors.
    Noda Y; Nabeshima T
    Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
    Shoemaker WJ; Kosten TA; Muly SM
    Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
    Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
    Zhu H; Barr GA
    Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Cappendijk SL; de Vries R; Dzoljic MR
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
    Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
    Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
    Medvedev IO; Dravolina OA; Bespalov AY
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with withdrawal signs of naloxone-induced opiate withdrawal under anesthesia is anesthetic-specific in opiate-dependent rats.
    Streel E; Dan B; Bredas P; Clement B; Pelc I; Verbanck P
    Life Sci; 2001 Dec; 70(5):517-22. PubMed ID: 11811896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.